Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sotagliflozin in patients with Type 1 diabetes mellitus and heart failure symptoms is currently recruiting, sponsored by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sotagliflozin (sotagliflozin)

Snippet

Sponsor: University of Dundee | Conditions: Type 1 Diabetes, Heart Failure | Phase 2 | Status: RECRUITING